Arkolith/Insider Trading/TSHA/Form 4

Session R.A. II

10% OwnerTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Mar 8, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2023Other(J)251K—$09.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2023Disposed to issuer(D)200K——0

Transaction Codes

J
Other acquisition / disposition
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-017342) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML